# Paclitaxel-induced Polyneuropathy in Breast Cancer: Early Detection, Risk Factors, Quality of Life and Lifestyle Outcomes

> **NCT06052345** · — · RECRUITING · sponsor: **Theodoros Foukakis** · enrollment: 100 (estimated)

## Conditions studied

- Breast Neoplasms
- Breast Cancer
- Early-stage Breast Cancer
- Non-Metastatic Breast Carcinoma
- Polyneuropathy Due to Drugs
- Polyneuropathy; Drug
- Chemotherapy-induced Peripheral Neuropathy
- Quality of Life

## Interventions

- **DEVICE:** Garmin smartwatch
- **OTHER:** REBECCA Mobile application
- **OTHER:** REBECCA PC plug-in

## Key facts

- **NCT ID:** NCT06052345
- **Lead sponsor:** Theodoros Foukakis
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-31
- **Primary completion:** 2025-12
- **Final completion:** 2026-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-03-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06052345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06052345, "Paclitaxel-induced Polyneuropathy in Breast Cancer: Early Detection, Risk Factors, Quality of Life and Lifestyle Outcomes". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06052345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*